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ABSTRACT 
Metabolic syndrome combines the risk factors for type 2 diabetes and cardiovascular 
disease, including obesity, insulin resistance, impaired glucose tolerance, dyslipidaemia and 
hypertension. Obesity is now understood to be a chronic low-grade inflammatory state with 
sustained oxidative stress. There are few drug therapies for obesity and all may produce 
unacceptable adverse effects. Thus, functional foods may serve as a better alternative for 
treatment of metabolic syndrome. Anthocyanins are purple-coloured polyphenolic compounds 
found in dark-coloured fruits and vegetables, such as purple carrot, Queen Garnet plum, 
chokeberry and purple corn. As anthocyanins produce anti-oxidant and anti-inflammatory 
responses, this study investigated whether anthocyanin-rich black rice can reverse the signs of 
diet-induced metabolic syndrome. This study used high-carbohydrate, high-fat diet-fed male 
Wistar rats to mimic the symptoms of human metabolic syndrome. Rats developed 
hypertension, diabetes along with damage to cardiovascular and hepatic systems. However, 
rats supplemented with cyanidin 3-glucoside rich black rice extract mid-way through the 
protocol had noticeable overall health improvements. Black rice extract reversed many changes 
the rats developed while on the diet including reduced body weight (10%), abdominal obesity 
(6%) and normalising systolic blood pressure; improved hepatic structure (decreased 
inflammation) and function; (decreased liver enzyme activity) improved cardiovascular 
structure (decreased inflammation and fibrosis) and function along with reduced overall 
cholesterol and decreased liver enzyme activity. 
Keywords: diet-induced metabolic syndrome, anthocyanin, cyanidin 3-glucoside, obesity 
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CHAPTER 1 
LITERATURE REVIEW AND INTRODUCTION 
1.1 Metabolic syndrome 
Metabolic syndrome refers to the co-occurrence of risk factors for cardiovascular 
disease and type 2 diabetes. These risk factors include hypertension, central obesity, insulin 
resistance, elevated fasting blood glucose concentrations, impaired glucose tolerance and 
dyslipidaemia (1, 2). Various definitions have been developed for the classification of 
metabolic syndrome. Four of these definitions given by World Health Organisation (WHO), 
European Group for the study of Insulin Resistance (EGIR), National Cholesterol Education 
Program Adult Treatment Plan III (NCEP ATP III) and International Diabetes Federation (IDF) 
are summarised in Table 1. The reported prevalence of metabolic syndrome varies according 
to the different parameters used to define this syndrome. 
Obesity as the major symptom of metabolic syndrome has reached epidemic 
proportions (3).  Obesity is characterised by low-grade inflammation with increased oxidative 
stress along with excessive fat deposition; obese individuals have a body mass index (BMI) of 
> 30kg/m2 (4). The prevalence of metabolic syndrome in adults from the United States of 
America during 1988-1994 was estimated at 18%, while during 1999-2006 it had increased to 
34.1% (5). More than 35% of men and women in the United States of America are classified 
as having obesity with a similar proportion of the population overweight too (6). In Australia, 
during 1999-2000, the prevalence of metabolic syndrome in adults aged over 25 years was 
estimated to be between 22% (using IDF definition) and 31% (using NCEP ATP III and WHO 
definitions) (7). The Australian Diabetes, Obesity and Lifestyle study in 2000 found that 
between 19.3% (using IDF definition) and 29.1% (using NCEP ATP III definition) of adults 
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aged 25 and over met the criteria for a diagnosis of metabolic syndrome (8). In Australia during 
2011-12, 64% of people aged 18 years or older were overweight or obese (BMI > 25 kg/m2) 
(9). The prevalence of obesity has increased over time from 56.3% in 1995, 61.2% in 2007-08 
and 62.8% in 2011-12 (9).  
Different definitions of metabolic syndrome provide a different prevalence rate due to 
the differences in definition. The IDF criteria for defining metabolic syndrome demonstrates 
the importance of treating risk factors in aged (64 years and older) individuals, especially 
higher fasting glucose and obesity, is important (10). A study compared the prevalence of 
metabolic syndrome and association with diabetes and cardiovascular disease using two 
definitions; it found prevalence of metabolic syndrome is higher using NCEP ATP III (odd-
ratio 7.0, 95% confidence-interval 5.3–9.4) definition compared to the IDF definition (odd-
ratio 4.7, 95% confidence-interval 3.4–6.3), which has a focus on prediabetes and type 2 
diabetes, in a Bangladeshi population (11). In a study using the NCEP ATP III and IDF 
definitions it was found the prevalence of metabolic syndrome is high (between 38.9% using 
IDF definition and 46.1% using NCEP ATP III definition) in a Sri Lankan population with an 
emphasis on glycaemic control in the IDF definition (12). A study into the prevalence of 
metabolic syndrome in elderly women (60-83 years) using different criteria to define metabolic 
syndrome found that the NCEP ATP III criteria is the best indicator to predict a cardiovascular 
event in this age group (13). In 2002, the prevalence of metabolic syndrome ranged from 8.8% 
to 14.3% in Finnish men aged 42 to 60 years depending on the definition used (14). The 
American Heart Association reported in 2012, 35% (using a definition similar to NCEP ATP 
III) of the adults in the United States of America would be classified as having metabolic 
syndrome (15). 
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In Russia during 2010, 9.5% of men and 24% of women had metabolic syndrome (16). 
In Asian populations, the IDF definition will miss a sizable number of Asians if used in 
screening probably due to the inadequacy of current methods to identify central obesity (17). 
In South-East Asia, metabolic syndrome is estimated at 24% using the NCEP ATP III definition 
(18). A study reported the prevalence of metabolic syndrome to be high in Karachi, Pakistan 
with estimates between 34.8% and 49% using the IDF and modified NCEP ATP III definitions, 
respectively (19). This epidemiological evidence from Russia, Pakistan, Bangladesh, Sri-
Lanka, South-East Asia, Finland, United States of America and Australia emphasises that 
metabolic syndrome is a global problem. 
The alteration of diet composition is recognised as one of the major causes of increasing 
metabolic syndrome prevalence (20). Replacement of complex dietary carbohydrates 
(polysaccharides) with simple sugars (monosaccharides or disaccharides) in conjunction with 
an excessive consumption of animal products leads to changes in dietary metabolic responses 
(20). These dietary changes, specifically increases in sugars and lipids (long–chain saturated 
and trans fats) can induce metabolic disturbances that potentiate the development of 
inflammation and oxidative stress (21). Inflammation and oxidative stress underpin many of 
the pathologies associated with metabolic syndrome (22-24) including cardiovascular structure 
and function including cardiac hypertrophy, endothelial dysfunction, cardiac fibrosis and 
ventricular contractile dysfunction (25). Inhibition of inflammation and oxidative stress using 
synthetic and natural compounds can attenuate the development of metabolic syndrome (26-
31). 
Different diagnostic criteria for metabolic syndrome have been proposed by different 
organisations over the past decade (32). The most appropriate definition for metabolic 
syndrome must consider age and ethnic differences and vary each parameter threshold value 
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accordingly (32). A single set of threshold values should be decided upon for very specific age 
ranges and ethnic groups. These improvements should streamline diagnosis and expedite 
treatments. 
5 
Table 1. Definitions of metabolic syndrome Source: (1) 
 
 
*IGT, impaired glucose tolerance; IFG, impaired fasting glucose; T2D, type 2 diabetes; IR, insulin resistance; other evidence includes  euglycemic clamp studies. 
†Urinary albumin excretion of > 20 µg/min or albumin-to-creatinine ratio of > 30 mg/g. 
‡Reliable only in patients without T2D. 
Criteria for central obesity (waist circumference) are specific for each population; values given are for European men and women. 
Rx, pharmacologic treatment. 
Abbreviations used: WHO, World Health Organisation; EGIR, European Group for the Study of Insulin Resistance; NCEP ATP III, National Cholesterol Education Program 
Adult Treatment Panel III; IDF, International Diabetes Foundation; TG, triglycerides; HDL-C, high density lipoprotein cholesterol.  
 WHO (1998) EGIR (1999) NCEP ATP III (2005 
revision) 
IDF (2005) 
Compulsory Insulin resistance* (IGT, IFG, T2D 
or other evidence of IR) 
Hyperinsulinemia (plasma 
insulin >75th percentile) 
None Central obesity  
Criteria Insulin resistance or diabetes, plus 
two of the five criteria below 
Hyperinsulinemia, plus two 
the four criteria below 
Any three of the five criteria 
below 
Obesity, plus two of the four 
criteria below 
Central obesity Waist: hip ratio (>0.90 in males, 
>0.85 in females) or BMI>30 kg/m2 
Waist circumference (>94 
cm in males, > 80 cm in 
females 
Waist circumference (>40 
inches in males, >35 inches in 
females 
Waist circumference (>94 
cm in males, > 80 cm in 
females 
Hyperglycaemia Insulin resistance already required  Insulin resistance already 
required 
Fasting glucose >100 mg/dl or 
Rx 
Fasting glucose >100 mg/dl 
Dyslipidaemia  
(Triglycerides) 
TG >150 mg/dl or 
HDL-C (<35 mg/dl in males, <39 
mg/dl in females 
TG >177 mg/dl or 
HDL-C <39 mg/dl 
TG >150 mg/dl or Rx 
 
TG > 150 mg/dl or Rx 
 
Dyslipidaemia  
(Cholesterol) 
HDL cholesterol (<40 mg/dl in 
males, <50 mg/dl in females or 
Rx 
HDL-C (<40 mg/dl in males, 
< 50 mg/dl in females or Rx 
Hypertension >140/90 mmHg >140/90 mmHg or Rx >130/85 mmHg or Rx >130/85 mmHg or Rx 
Other criteria Microalbuminuria†    
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Cardiovascular disease, including coronary heart disease, ischaemic heart disease and 
stroke, remains the leading cause of death around the world. The Global Burden of Disease 
study conducted in 2010 estimated that 29.6% of all deaths worldwide were caused by 
cardiovascular disease (33). There were 52.8 million deaths globally in 2010 of which 
ischaemic heart disease and stroke accounted for 12.9 million (34). Deaths caused by strokes 
are expected to increase to 23.6 million people worldwide in 2030 (35). 
Global obesity (BMI of > 30kg/m2) prevalence has more than doubled since 1980. In 
2008, more than 1.4 billion adults aged 20 or more years were overweight or obese with 500 
million adult men and women defined as obese (36). Obesity is a complex condition which is 
associated with co-morbidities including cardiovascular disease, type 2 diabetes and non-
alcoholic fatty liver disease (37). In 2003, global prevalence of type 2 diabetes was 194 million 
which is predicted to increase to 334 million in 2025 (38). Type 2 diabetes further increases 
the risk of cardiovascular disease. The increasing worldwide prevalence of metabolic syndrome 
increases the proportion of people who are suffering from type 2 diabetes and cardiovascular 
disease and hence increases the burden on the healthcare system (3). Cardiovascular disease 
represents a major economic burden with an estimated healthcare cost of USD 457.4 billion in 
2006 (39) and this cost is expected to increase with the increase in prevalence of metabolic 
syndrome. 
Recently, it has been identified that the gut microflora plays an important role in 
regulating health as altered gut microbiota can contribute to the induction of many disease 
states including obesity (40). The gut microbiota contains 1013 to 1014 microorganisms which 
equates to approximately 1.5 to 2 kilograms of bacteria. Gut microbiota interact with all 
consumed foods and therefore represent an important aspect of metabolism. This gut 
microbiota can modify the nutrient availability and uptake and consequently may define the 
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metabolism of the host. Similarly, a particular type of diet can selectively increase a particular 
population of gut microbiota (40). The selective increase of beneficial bacteria in the gut can 
be used as a strategy to improve metabolic syndrome. 
However, the current body of knowledge is insufficient to evaluate the additional 
functions of foods. In order to identify foods that may provide health benefits beyond basic 
nutritional requirements, it is important to identify their physiological activities in chronic 
diseases (4). Many foods from plants contain polyphenols, a group of non-nutritive compounds 
that may produce the physiological responses to foods (41). Polyphenols are secondary plant 
metabolites synthesised from shikimate pathway products containing more than one phenolic 
ring and devoid of any nitrogen-based functional groups in their most basic structure (41). 
Flavonoids are a class of polyphenols that are found in fruits and vegetables which have 
potential beneficial health effects. Anthocyanins belong to the flavonoids class of polyphenols 
and they are water-soluble dark coloured natural pigments from fruits and vegetables (42). 
1.2 Anthocyanins: structure and sources 
Anthocyanins are water-soluble flavonoid pigments that, depending on pH, contribute 
a diverse range of colours including purple, red and dark blue seen in many fruits and 
vegetables (43). For example, chokeberry is extremely rich in the content of these pigments 
(44, 45). Anthocyanins are used as natural colouring agents because of the high content of 
anthocyanins in some fruits and vegetables (46). Anthocyanins have anti-oxidative and anti-
inflammatory activities and these properties of anthocyanins can be helpful in providing health 
benefits against chronic diseases (47). Anthocyanins are susceptible to heat, light and pH 
changes as well as oxidation (48). Anthocyanidin is the aglycone (sugar-free) form of the 
anthocyanin compound. There are at least six main types of anthocyanidins: pelargonidin, 
cyanidin, delphinidin, peonidin, petunidin and malvidin. Cyanidins are the most widely 
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distributed species (49). Three of the major anthocyanidins found in nature are cyanidin, 
delphinidin and malvidin (48) and are shown below in Figure 1. 
 
Figure 1. Structure of anthocyanidins 
Chemically, anthocyanins are based on a single basic core structure, the flavylium ion. 
Anthocyanins have a C6-C3-C6 skeleton with a positive charge in their structure at acidic pH. 
The structure of common anthocyanins is presented in Figure 2 and the three side groups are 
presented in Table 2. 
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Figure 2. Structure of anthocyanins Source: (43) 
 
Table 2. Structure of anthocyanins Source: (43) 
 
 
  
Names R1 R2 R3 
Pelargonidin H H H 
Cyanidin OH H H 
Delphinidin OH OH H 
Peonidin OCH3 H H 
Petunidin OCH3 OH H 
Malvidin OCH3 OCH3 H 
Pelargonidin-3-0-glucoside H H Glu 
Cyanidin-3-0-glucoside OH H Glu 
Delphinidin-3-0-glucoside OH OH Glu 
Peonidin-3-0-glucoside OCH3 H Glu 
Petunidin-3-0-glucoside OCH3 OH Glu 
Malvidin-3-0-glucoside OCH3 OCH3 Glu 
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Major sources of dietary anthocyanins include fruits and vegetables including berries 
(blueberry, billberry, Saskatoon berry and chokeberry), purple carrot, blackcurrant, plum, red 
radish, purple corn, purple cabbage and purple sweet potato (35, 50, 51). Anthocyanin 
concentrations in different foods are presented in Table 3. 
Table 3. Concentrations of anthocyanins in various foods Source: (52) 
Food source Major type(s) of anthocyanidin 
Concentration (mg/100g 
fresh weight) 
Apple (Red Delicious) 
Cyanidin 
Pelargonidin 
12.1 
0.2 
Chokeberry 
Cyanidin 
Pelargonidin 
1478 
2.3 
Black bean 
Delphinidin 
Petunidin 
Malvidin 
18.5 
15.4 
10.6 
Black plum Cyanidin 124.5 
Wild blueberry 
Delphinidin 
Cyanidin 
Petunidin 
Peonidin 
Malvidin 
141.1 
66.3 
87.6 
36.9 
154.6 
 
1.3 Metabolism and pharmacokinetics of anthocyanins 
The anthocyanin group is now known to have many beneficial health effects (53). 
However, information on pharmacokinetics in humans is scarce (54, 55). Studies have 
investigated the absorption of flavonoids after controlled oral administration of 
pharmacological doses rather than following regular dietary consumption of flavonoids (54). 
Anthocyanins are extensively metabolised with only 1.5 to 5.1% of anthocyanins recovered in 
urine within 12 hours after wine consumption (54). Depending on nutritional habits in humans, 
total daily flavonoid consumption is estimated to be a few hundred milligrams (56). Although 
the total anthocyanin consumption is substantially lower, consumption of the Queen Garnet 
plum containing of 272 mg/100 g fresh fruit, so 5-10 fold higher than other plums (57), should 
markedly increase anthocyanin intake. When taken in the diet, anthocyanins are absorbed from 
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the stomach (58) and intestinal cells (59) and rapidly detected in plasma in vivo (54). The major 
metabolites of cyanidin 3-glucoside are protocatechuic acid and 4-hydroxybenzoic acid (60). 
These two metabolites exert both anti-inflammatory and anti-oxidative effects and are therefore 
considered the active metabolites responsible for the systemic health benefits (60). 
Cyanidin 3-glucoside is highly metabolised during the first pass effect (60). 
Anthocyanins, in general, are present in the circulation for less than 48 hours after ingestion 
(61). A tracer metabolite (13C-labeled anthocyanin) was used to investigate the absorption, 
distribution, metabolism and elimination in humans (61). This study established a minimum 
relative bioavailability for cyanidin 3-glucoside of 12.38 ± 1.38% on the basis of the total 
elimination of the absorbed 13C dose (49). The metabolites identified as degradation products 
included phenolic acid, hippuric acid, phenylacetic acid and phenylpropenoic acid (49). This 
study concluded that anthocyanins are more bioavailable than previously perceived, and their 
metabolites are present in the circulation for  more than 48 hours after ingestion (49). Other 
pharmacokinetic studies have shown that plasma anthocyanins peak approximately one hour 
after oral consumption and then rapidly decrease (62). 
Anthocyanin glycosides are hydrolysed into their anthocyanidin (aglycons) form by the 
intestinal microbiota in as little as 20 minutes to as long as 2 hours after incubation depending 
on the sugar moieties present (49). The Caco-2 cell line is a human epithelial cell model derived 
from a colon carcinoma, proven to be a good alternative to animal studies predicting intestinal 
absorption of anthocyanins (63). A study using this cell line found that although bioavailability 
of anthocyanins is very low, anthocyanins from several different food sources (including 
blackberry, blueberry, plum, black rice and grape) exert health benefits through anti-
proliferative, anti-oxidant and anti-inflammatory actions (63). Although it is unknown whether 
anthocyanins accumulate in the cardiac or vascular tissues during long-term feeding, animal 
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studies have demonstrated that anthocyanins affect vascular reactivity (64). Relatively low-
dose anthocyanin interventions with patients clinically diagnosed with vascular diseases have 
been associated with significant reductions in ischemia, blood pressure, lipid levels and 
inflammatory status (64). 
1.4 Anthocyanin functions 
Anthocyanins have anti-oxidative and anti-inflammatory properties (53, 65), decrease 
plasma concentrations of total cholesterol, LDL-cholesterol and triglycerides and inhibit 
enzymes responsible for fatty acid synthesis in rats (42). In previous studies, anthocyanins from 
purple carrots and Queen Garnet plums have shown beneficial effects against diet-induced 
metabolic syndrome (28, 57). In high-carbohydrate, high-fat diet-fed rats, purple carrot juice 
(5 % in food for 8 weeks; providing 15 mg/kg/day of cyanidin 3-glucoside) reduced systolic 
blood pressure, abdominal obesity, plasma lipids and body weight while improving glucose 
tolerance and structure and function of the heart and liver (28). In a recently published study, 
the Queen Garnet plum juice has shown very similar results with a lower concentration of 
cyanidin 3-glucoside (~8 mg/kg/day) being used for the treatment of obese rats (57). Based on 
these results, and the fact that the same active ingredient (cyanidin 3-glucoside) is being 
investigated from different sources, it can be suggested that many other food sources will have 
similar health effects in terms of physiological responses, e.g. reduction in systolic blood 
pressure. However, the variation in, types and concentrations of anthocyanins between dark-
coloured food products may result in different responses which needs to be proven. This study 
has extended the evidence in supporting the responses provided by cyanidin 3-glucoside in 
attenuating metabolic syndrome in diet-induced rats.  
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1.5 Black Rice 
Black rice (Oryza sativa L.) also known as purple rice has a seed coat containing 
anthocyanins, mainly cyanidin 3-glucoside (66). Black rice also contains phytosterols (24-
methylene-ergosta-5-en-3β-ol, 24-methylene-ergosta-7-en-3β-ol, fucosterol, gramisterol, 
campesterol, stigmasterol and β-sitosterol) and triterpenoids (cycloeucalenol, lupenone, lupeol 
and 24-methylenecycloartanol) at much smaller concentrations (67). Some of these 
phytosterols and triterpenoids have shown their physiological responses (67). This study used 
a concentrated black rice extract provided by ChromaDex with ~36% of the extract as cyanidin 
3-glucoside. 
1.6 Cyanidin 3-glucoside 
Cyanidin 3-glucoside (Figure 2, Table 2), a secondary metabolite produced by many 
plants, is an anthocyanin (68). It is a one of the major anthocyanins in many berries, purple 
carrots, plums and black rice (66, 69, 70). Below is the literature related to proven biological 
activities of cyanidin 3-glucoside. 
 
  Figure 3. Structure of cyanidin 3-glucoside 
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1.7 In vitro studies 
Anthocyanins from black soybean (72% was cyanidin 3-glucoside) at a dose of 10 
μg/mL in a cell culture of human umbilical vein endothelial cells were used to investigate 
potential health benefits (71). In this study, black soybeans preferentially inhibited TNF-α-
mediated induction of vascular cell adhesion protein 1 over intercellular adhesion molecule 1 
(71). These results indicate the possible role that anthocyanins have for the molecular 
regulation of inflammatory pathways. The flavonol and anthocyanin subclasses have also been 
inversely associated with biomarkers of adiposity-associated inflammation, including 
increased TNF-α, IL-6, and hs-CRP (72). Delphinidin reduced the oxidised low-density 
lipoprotein (ox-LDL) levels in human umbilical vein endothelial cells (49, 73) and hence 
protected human umbilical vein endothelial cells against ox-LDL-induced injury (49). 
Cyanidin 3-glucoside extracted from purple corn has shown health benefits in in vitro 
and animal studies especially as an anti-oxidant (35). These findings clearly indicate that 
cyanidin 3-glucoside has significant potency in anti-diabetic effects by modulating the c-Jun 
N-terminal kinase/FOXO1 signalling pathway and the related inflammatory adipocytokines 
(35). 
Anthocyanins from black soybean seed coats (72% cyanidin 3-glucoside, 20% 
delphinidin 3-glucoside and 6% petunidin 3-glucoside) reduced TNF-α-mediated vascular cell 
adhesion protein 1 induction in a concentration-dependent manner (10, 50 and 100 μg/mL) in 
human umbilical vein endothelial cells (71). In the same cell line, delphinidin inhibited ox-
LDL-induced cell viability loss primarily by up-regulating proteins involved in inhibiting 
apoptosis including Bcl-2 and Bax proteins (62). These results suggest that the responses to 
anthocyanins supplementation may be mediated by its anti-inflammatory and anti-apoptotic 
properties and up-regulation of the insulin-signalling cascade (62). 
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1.8 Animal studies 
Chokeberry extract (106.8 mg cyanidin 3-glucoside/100 mL juice) reduced body 
weight gain and abdominal fat, reduced the cardiovascular risk factor related to metabolic 
syndrome (having an anti-hyperlipidaemic effect) in plasma and modulated multiple signalling 
pathways related to adipose dysfunction in a rat model (46). A study found that chokeberry 
fruit juice (5, 10, and 20 mL/kg body weight) for 30 days reduced total cholesterol, LDL-
cholesterol and triglycerides in 4% cholesterol diet-fed rats (46). Chokeberries (100 and 200 
mg/kg/day) also reduced visceral adiposity, blood glucose, serum triglycerides, total 
cholesterol and LDL-cholesterol in fructose-fed rats (44). In the same study, anthocyanin 
supplementation increased plasma adiponectin levels, inhibited the plasma levels of pro-
inflammatory cytokines such as TNF-α and IL-6, down-regulated adipogenic markers (GSK3β, 
FABP4, FAS and LPL) with mRNA expression and up-regulated important intermediates of 
the insulin signalling cascade (IRS1, IRS2, PI3K, GLUT1, GLUT4 and GYS1) (44). In 
diabetes induced by high-fructose diet and simultaneous single injection of streptozotocin (20 
mg/kg), dietary supplementation with chokeberry fruit extract (0.2% in food; ~400 mg/g of 
anthocyanin glycosides in the extract) decreased antioxidant status of vital organs, total plasma 
cholesterol and blood glucose concentrations (45). In Zucker rats fed a high-fat diet, 
supplementation with 2% dietary blueberry or 1% whole tart cherry powder reduced plasma 
triglycerides, fasting insulin, homeostatic model assessment insulin resistance. Furthermore, 
there was a reduction in abdominal fat mass and increased adipose and skeletal muscle 
peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ activity along with 
reductions in TNF-α, IL-6 and nuclear factor-κB (NF-κB) in the plasma and the adipose tissue 
and improved glucose tolerance (74). At the same dosage after 90 days, tart cherries reduced 
fasting blood glucose, hyperlipidaemia, hyperinsulinemia and fatty liver with increased hepatic 
PPAR-α expression in salt-sensitive Dahl rats (75).  
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Anthocyanin extract from black rice (5 g/kg diet) lowered body weight gain and serum 
triglyceride, raised hepatic carnitine palmitoyltransferase 1 expression and inhibited platelet 
hyperactivity suggested by decreased thromboxane A2, the thrombogenic ratio of thromboxane 
A2 and prostacyclin, serum calmodulin and soluble P-selectin expression in high fat diet-fed 
rats (76). Studies in animal models have shown the flavonoid subclass, anthocyanins, improved 
glucose metabolism, insulin resistance and β-cell dysfunction through GLUT4 regulation. 
Blackcurrants improved endothelial function by increasing nitric oxide synthesis which 
subsequently induces endothelium-dependent vasorelaxation via the H1-recprotes on the 
endothelium in isolated rat aortic rings (77). These effects were abolished by nitric oxide-
cGMP inhibitors suggesting the role this signalling pathway in anthocyanin-mediated 
vasodilation (78). 
Cyanidin 3-glucoside reduced body weight gain and attenuated obesity-associated 
dyslipidaemia and insulin resistance in high-fat diet-fed rats by increasing serum adiponectin 
level (48, 79). Rats supplemented with cyanidin and its glucoside increased adiponectin and 
leptin secretion along with the stimulation of AMP-activated protein kinase (80). Cyanidin 3-
glucoside ameliorated insulin sensitivity by down-regulating the retinol binding protein 4 
expression in diabetic mice (41). Cyanidin 3-glucoside attenuated obesity-associated insulin 
resistance and hepatic steatosis in high-fat diet-fed and db/db mice potentially via the up-
regulation of transcription FOXO1 (81). A study with bayberry fruit extract, containing 
cyanidin 3-glucoside, protected pancreatic β-cells and ameliorated oxidative stress-induced 
injury along with reduced blood glucose concentration in diabetic mice (69). Cyanidin 3-
glucoside lowered fasting glucose levels and markedly improved insulin sensitivity in both 
high fat diet-fed and db/db mice compared with untreated controls (81). Cyanidin 3-glucoside 
17 
 
has shown the potential to improve insulin resistance and its consequences in 3T3-L1 
adipocytes through the upregulation of GLUT4 gene expression (68). 
White adipose tissue mRNA levels and serum concentrations of inflammatory 
cytokines (TNF-α, IL-6 and monocyte chemoattractant protein-1) were reduced by cyanidin 3-
glucoside, as were macrophage infiltration in adipose tissue (81). Concomitantly, hepatic 
triglyceride content and steatosis were alleviated by cyanidin 3-glucoside (81). Moreover, 
cyanidin 3-glucoside treatment decreased c-Jun N-terminal kinase activation and promoted 
phosphorylation and nuclear exclusion of FOXO1 after refeeding (81). 
From the research studies on animal (rats and mice), it is evident that anthocyanins have 
many health benefits, in summary, improved lipid profile, blood glucose, endothelial function, 
inhibited pro-inflammatory cytokines, attenuated inflammation, all while a high-fat diet was 
still fed the animals. Anthocyanins also up-regulated gene expression in glucose transporters 
leading to improvements of diabetes. These studies have shown many health benefits. Animal 
studies have not been able to translate to human clinical trials. This step is necessary to provide 
evidence-based research to support the right dosages and study technique to treat human 
diseases. The gap in knowledge occurs in human studies where anthocyanins are notoriously 
difficult to study. Details on the mechanisms of action for bioactivity, uptake, absorption, 
bioavailability, whole body distribution, and tissue localisation are still not fully understood 
(82). 
1.9 Human studies 
An epidemiological study of a large group (n=200,894 people) found that a higher 
consumption of anthocyanins and anthocyanin-rich fruit was associated with a lower risk of 
type 2 diabetes (83). Human studies aim to extend the therapeutic responses produced in animal 
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models to dietary anthocyanins. In patients with metabolic syndrome, chokeberry extract (3 x 
100 mg/day) was given for two months. The results were decreased systolic and diastolic blood 
pressure, endothelin-1, total cholesterol, LDL-cholesterol, triglycerides, thiobarbituric acid 
reactive substance, catalase activity and induced superoxide dismutase activity (42). Clinical 
studies show little effect of pro-inflammatory markers on healthy human participants (64). 
However, one study showed significant improvements of plasma risk biomarkers after 
supplementation with anthocyanins (84). Consumption of anthocyanin-rich foods and 
beverages improved endothelium-dependent vasodilation in humans (78). In 
hypercholesterolaemic patients, 320 mg/day of purified anthocyanins isolated from bilberries 
and blackcurrants increased brachial artery flow-mediated dilatation and HDL-cholesterol 
concentrations and decreased the serum soluble vascular cell adhesion protein 1 and LDL-
cholesterol concentrations (64). 
Anthocyanins have health benefits evidenced in in vitro, animal and human studies. 
Based on a previous study in this laboratory and literature discussed for anthocyanins, this 
honours project characterised the effects of cyanidin 3-glucoside from black rice in diet-
induced metabolic syndrome rats. Structural improvements in the rat heart were identified 
through histology and heart function through isolated perfusion heart studies (ex vivo). Systolic 
blood pressure was measured and isolated thoracic rings were used to measure vascular 
reactivity. Biochemical parameters (enzyme activities of alanine transaminase, aspartate 
transaminase and alkaline phosphatase) were assessed along with plasma lipid profile. Liver 
structural changes were defined through histopathological analysis. Small and large intestine 
structural changes were identified through histopathological analysis.  
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials 
 Black rice extract for this study was kindly provided by ChromaDex, Irvine, CA, USA. 
Beef tallow was purchased from Carey Brothers, Warwick, QLD, Australia. Condensed milk 
was purchased from Coles Kearney Springs, Toowoomba, QLD, Australia. Meat-free 
powdered rat food was purchased from Speciality Feeds, Glen Forrest, WA, Australia. Hubble, 
Mendel and Wakeman salt mixture was purchased from MP Biomedicals, Seven Hills, NSW, 
Australia. Fructose was purchased from Tate & Lyle, Wacol, QLD, Australia. Corn starch was 
purchased from Agri Food Ingredients, Kew East, VIC, Australia. All laboratory chemicals 
were purchased from Sigma-Aldrich Australia, Castle Hill, NSW, Australia, unless otherwise 
specified at their first appearance in text. 
2.2 Rats, experimental groups and housing 
 All experimental protocols were approved by the Animal Ethics Committee of the 
University of Southern Queensland (Project number – 13REA005) under the guidelines of the 
National Health and Medical Research Council of Australia. The experimental protocol 
consisted of 48 male Wistar rats (8-9 weeks old; 339 ± 2 g) purchased from the Animal 
Resource Centre, Murdoch, WA, Australia. Rats arrived a week before they were started on 
diets and these rats were acclimatised for one week on laboratory chow diet. Rats were 
randomly divided into following four experimental groups (n = 12 rats/group): 
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1. C – rats received corn starch (CS) diet for 16 weeks 
2. CBRE – rats received CS diet for the initial 8 weeks and then CS diet was supplemented 
with 400 mg black rice extract/kg food for the last 8 weeks. 400 mg black rice extract 
containing 36% cyanidin 3-glucoside was added to each kilogram of CS food. This 
concentration was calculated based on the dose of cyanidin 3-glucoside used in the previous 
study with Queen Garnet plum and pure cyanidin 3-glucoside (57) of 8 mg/kg body 
weight/day. 
3. H – rats received high-carbohydrate, high-fat (HCHF) diet for 16 weeks 
4. HBRE – rats received HCHF diet for the initial 8 weeks and then HCHF diet was 
supplemented with 400 mg black rice extract/kg food for the last 8 weeks. 
This protocol is represented in detail in Figure 4. All rats were housed in a temperature-
controlled (21 ± 2ºC) room with an automated 12-hour light & dark cycle environment. All rats 
were housed in individual cages in the animal house at the University of Southern Queensland, 
Toowoomba campus and had ad libitum access to diet and water. 
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Figure 4. Timeline of the 16-week experimental protocol. SBP, systolic blood pressure; 
OGTT, oral glucose tolerance test; CS, corn starch diet; HCHF, high-carbohydrate, high-fat 
diet. 
2.3 Diets 
All group-specific diets were custom-prepared in the animal house food preparation 
room. The CS diet was prepared by thorough mixing of corn starch (570 g), powdered rat food 
(155 g), Hubble, Mendel and Wakeman salt mixture (25 g) and water (250 g) per kilogram of 
diet. The HCHF diet was prepared by thorough mixing of fructose (175 g), condensed milk 
(395 g), beef tallow (200 g), powdered rat food (155 g), Hubble, Mendel and Wakeman salt 
mixture (25 g) and water (50 g). C and CBRE rats were given tap water whereas H and HBRE 
rats were given 25% fructose (w/v) in drinking water. The energy densities of CS and HCHF 
diets were 11.23 kJ/g and 17.83 kJ/g, respectively, and an additional 3.85 kJ/mL in the drinking 
water for the HCHF diet–fed groups (H and HBRE rats). Energy content was calculated from 
the following values in kilojoules per gram: fructose, 15.40; corn starch, 15.94; condensed 
milk, 13.80; beef tallow, 37.70; and powdered rat food, 13.80. 
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2.4 Daily measurements 
Rats were measured daily for their body weights and intakes of food and water. During 
these measurements, day-to-day health of rats was also monitored. Bedding of rats was changed 
regularly to provide cleaner housing for all rats. Energy intake of rats was calculated from the 
energy densities of CS and HCHF diets. Feed conversion efficiency was calculated using the 
following formula (26): 
Feed conversion efficiency =   
mean body weight gain (g)
daily energy intake (kJ)
  
2.5 Systolic blood pressure measurement 
Systolic blood pressure was measured at 0, 8 and 16 weeks under light sedation by 
intraperitoneal injection with Zoletil (tiletamine 10 mg/kg, zolazepam 10 mg/kg; Virbac, 
Peakhurst, NSW, Australia). Measurements were performed using an MLT1010 Piezo-Electric 
Pulse Transducer (ADInstruments, Bella Vista, NSW, Australia) and an inflatable tail-cuff 
connected to an MLT844 Physiological Pressure Transducer (ADInstruments) connected to a 
PowerLab data acquisition unit (ADInstruments) (26). The calibration of a transducer was 
performed on the day of the measurement using a pressure meter according to instructions 
provided by the manufacturer. Before the beginning of the sedation protocol, room temperature 
was set to 25ºC. After the rats were sedated, their tails were inserted through the tail cuff and 
the transducer was wrapped around the tail next to the cuff. A trace was detected for the blood 
pressure and five to six individual systolic blood pressure readings were taken for each rat and 
the average was calculated for each rat before using it for group calculations. After the blood 
pressure measurements, rats were given 5 mL of saline via sub-cutaneous injection on the 
dorsal side to prevent dehydration. Rats are then allowed to recover from sedation before 
returning to their individual cages. During the recovery period, rats were monitored every 
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fifteen minutes for the first hour with subsequent monitoring once every hour until the rat had 
completely recovered. 
2.6 Abdominal circumference 
Abdominal circumference was measured at 0, 8 and 16 weeks on sedated rats 
(immediately after systolic blood pressure measurement). A standard measuring tape was used 
to measure the circumference of the abdomen in the ventral recumbent position. The area 
measured is the soft tissue superior to the hind legs (26). 
2.7 Oral glucose tolerance test 
Oral glucose tolerance test was performed at 0, 8 and 16 weeks. For oral glucose 
tolerance test, rats were deprived of food overnight (6pm to 6am) in individual cages. For 
overnight food deprivation period, all types of diet were removed from their cages and fructose-
supplemented drinking water in the H and HBRE groups was replaced with tap water. After 
the overnight food deprivation period, basal blood glucose concentrations were determined in 
tail vein blood using Medisense Precision Q.I.D. glucometer (Abbott Laboratories, Bedford, 
MA). Rat tails were pricked with a 30 gauge needle to obtain a drop of blood which was then 
transferred onto a glucose strip (Freestyle Optium Blood Glucose Test Strips, Abbott Diabetes 
Care Ltd., Witney, Oxon, UK) attached to the glucometer. After recording this initial 0 minute 
blood glucose concentration, all rats were given 40% aqueous glucose solution (2 g glucose/kg 
body weight) via oral gavage using a 5 mL syringe and a 18 gauge plastic gavage needle. Tail 
vein blood samples were taken at 30, 60, 90 and 120 minutes following glucose administration 
(26). Rats were returned to their group-specific diets after the last blood glucose concentration 
measurement. The area under the curve (AUC) was calculated from the graph showing blood 
glucose concentrations against time. 
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2.8 Body composition measurement 
Body compositions of rats were measured using dual-energy X-ray absorptiometry 
(DXA) after 16 weeks of feeding protocol. These measurements were performed using a 
Norland XR36 DXA instrument (Norland Corp., Fort Atkinson, WI, USA). Rats were 
transported to The University of Queensland, St Lucia campus, Brisbane, in a University of 
Southern Queensland air-conditioned vehicle. For DXA scans, rats were anaesthetised using 
intraperitoneal injection of Zoletil (tiletamine 10 mg/kg and zolazepam 10 mg/kg) and Ilium 
Xylazil (xylazine 6 mg/kg; Troy Laboratories, Smithfield, NSW, Australia). These DXA scans 
recorded bone mineral density, bone mineral content, lean mass and fat mass and were analysed 
using the manufacturer’s recommended software for use in laboratory animals (Small Subject 
Analysis Software, version 2.5.3/1.3.1; Norland Corp.). The precision error of lean mass for 
replicate measurements, with repositioning, was 3.2% (75). After the scans were completed, 
rats were given 5 mL of saline via sub-cutaneous injection on the dorsal side to prevent 
dehydration. Rats were maintained at 25°C to prevent hypothermia. Rats were monitored as 
described for systolic blood pressure measurements. Rats were then taken back to the 
University of Southern Queensland, Toowoomba campus and returned to their respective cages 
in the animal house facility with free access to their respective diets and water. 
2.9 Terminal euthanasia and Langendorff heart preparation 
Terminal euthanasia was induced via intraperitoneal injection of Lethabarb 
(pentobarbitone sodium, 100 mg/kg; Virbac, Peakhurst, NSW, Australia). Once euthanasia was 
induced in rats, heparin was administered (200 IU) into the right femoral vein. The abdomen 
was then opened and blood (~6 mL) was withdrawn from the abdominal aorta, collected into 
heparinised tubes and centrifuged at 5000  g for 15 minutes within 30 minutes of collection 
to obtain plasma. Plasma from each rat was transferred to five Eppendorf tubes and stored at   
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-20ºC before analysis. Hearts were removed and used in isolated Langendorff heart mode to 
assess left ventricular function of the rats. Hearts isolated from rats were perfused with a 
modified Krebs-Henseleit bicarbonate buffer containing (in mmol/L): NaCl, 119.1; KCl, 4.75; 
MgSO4, 1.19; KH2PO4, 1.19; NaHCO3, 25.0; glucose, 11.0; and CaCl2, 2.16. Buffer was 
bubbled with 95% O2–5% CO2 and maintained at 35ºC. Isovolumetric ventricular function was 
measured by inserting a latex balloon catheter into the left ventricle connected to a Capto SP844 
MLT844 physiological pressure transducer and Chart software on a Maclab system. All left 
ventricular end-diastolic pressure values were measured during pacing of the heart at 250 
beats/minute using an electrical stimulator. End-diastolic pressures were obtained from 0 to 30 
mmHg for calculation of diastolic stiffness constant (κ, dimensionless) (26). 
2.10 Thoracic aortic organ bath 
 The thoracic aorta was isolated from the rat after blood collection and heart removal. 
The thoracic aorta was placed in a vessel filled with Tyrode’s physiological salt solution 
bubbled with 95% O2–5% CO2 and maintained at 35ºC. Tyrode’s physiological salt solution 
contains (in mmol/L): NaCl, 136.9; KCl, 5.4; CaCl2, 1.8; MgCl2.H2O, 1.05; NaH2PO4.H2O, 
0.42; NaHCO3, 22.6; C6H12O6, 1.8; ethylenediaminetetraacetic acid, 0.05; ascorbic acid (BDH 
laboratory supplies, Poole, UK), 0.3; glucose, 5.5. The fat around the aorta was carefully 
removed to expose the underlying tissue. Rings of approximately 4 mm in length were cut from 
each aorta. The rings were mounted onto the organ bath apparatus and allowed to stabilise at a 
resting tension of ~10 mN. Following stabilisation, submaximal (~70%) contraction was 
induced using noradrenaline to study the relaxation effect. One bath was kept intact to study 
the noradrenaline-induced contraction. After stabilisation, the cumulative concentration 
response curves (contraction) were obtained for noradrenaline and the cumulative 
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concentration-response curves (relaxation) were obtained for acetylcholine and sodium 
nitroprusside following submaximal (~70%) contraction (26). 
2.11 Ileum and colon organ bath 
 Distal ileum and distal colon were isolated from rats. These pieces were cleaned using 
Tyrode solution and were then cut into ~1 cm long pieces. The ileum and colon tissues were 
then stitched using fine thread and suspended in an organ bath filled with Tyrode physiological 
salt solution bubbled with 95% O2–5% CO2 and maintained at 35ºC and allowed to stabilise at 
a resting tension of ~10 mN. Concentration-response curves were obtained for acetylcholine 
by measuring responses to individual concentrations of acetylcholine. 
2.12 Organ weights 
After performing Langendorff heart perfusion, hearts (n = 10) were separated into right 
ventricle and left ventricle with septum for weighing. Livers and abdominal fat pads 
(retroperitoneal, epididymal and omental) were isolated and weighed (n = 12). These organ 
weights were normalised relative to the tibial length at the time of their removal (in mg of 
tissue/mm of tibial length) (26). 
Visceral adiposity index was calculated as follows: 
Visceral adiposity index (%) =  
retroperitoneal fat (g) + omental fat (g) + epididymal fat (g)
body weight (g)
 x 100 
2.13 Histology 
 Two rats were exclusively used for histopathological analysis from each group. Tissues 
were also collected from two other rats in each group. The heart, liver, small intestine and large 
intestine of rats were used for histopathological analysis. Two slides were prepared per tissue 
specimen and two random, non-overlapping fields per slide were taken to avoid biased analysis. 
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Approximately 5-7 minutes after euthanasia, heart, liver, small intestine and large intestine 
portions were collected and fixed in 10% neutral buffered formalin for 3 days. The samples 
were then dehydrated and embedded in paraffin wax. Thin sections (5 μm) of the samples were 
cut and stained with haematoxylin and eosin for determination of inflammatory cell infiltration 
(20) and liver fat vacuole presence (40). Collagen distribution was defined in the heart with 
picrosirius red stain. EVOS FLC microscope (Tokyo, Japan) was used to capture images for 
the above-mentioned slides to determine the extent of collagen deposition in selected tissue 
sections. Small intestine and large intestine sections were stained with haematoxylin and eosin 
stain to identify inflammatory cells (26). 
2.13 Biochemical analyses 
Plasma collected during terminal experiments were used to test for enzyme activities 
and plasma concentrations of biochemical markers. Plasma activities of alanine transaminase 
(ALT), aspartate transaminase (AST), and plasma concentrations of total cholesterol and 
triglycerides were determined at the School of Veterinary Sciences, The University of 
Queensland using kits and controls supplied by Olympus (Japan, Tokyo) using an AU 400 
Olympus analyser (26). Non-esterified fatty acids were determined using a commercial kit 
(Wako Diagnostics, Osaka, Japan) (26) at the School of Veterinary Sciences, The University 
of Queensland Gatton campus. 
2.14 Statistical analysis 
 All data are presented as mean ± standard error margin (SEM). Results were tested for 
variance using Bartlett’s test and variables that are not normally distributed were transformed 
(using log10 function) prior to statistical analyses. Data from C, CBRE, H and HBRE groups 
were tested by two-way analysis of variance. When the interactions and/or the main effects 
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were significant, means were compared using the Newman-Keuls multiple comparison post 
hoc test.  Where transformations did not result in normality or constant variance, a Kruskal-
Wallis non-parametric test was performed. A P-value of <0.05 was considered as statistically 
significant. All statistical analyses were performed using Prism version 5.00 for Windows 
(GraphPad Software, San Diego, CA, USA).  
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CHAPTER 3 
RESULTS 
3.1 Black rice extract composition and dosage 
The main anthocyanin present in black rice extract was cyanidin 3-glucoside at 36% 
with 2% of other anthocyanins (not individually identified)  information provided by 
ChromaDex (Irvine, CA, USA). 400 mg of black rice extract/kg food was administered to rats 
in CBRE and HBRE groups to obtain the dosage of cyanidin 3-glucoside 8 mg/kg of rat body 
weight, however the average daily intake of cyanidin 3-glucoside were higher in CBRE rats 
than in HBRE rats due to the higher food intake (Table 4). 
3.2 Physiological variables 
Rats were fed with their group-specific diet for 16 weeks. During 16 weeks of the 
protocol, C rats slowly increased their body weight (Figure 5A). CBRE rats were higher in 
body weight than the C rats at the end of 8 weeks. This difference was visible at the end of 16 
weeks where body weight of CBRE rats was higher than C rats (Figure 5A). The increase in 
body weight of H rats was faster than C rats and they had higher body weight compared to C 
and CBRE rats at the end of 16 weeks. Supplementation of black rice extract for the last 8 
weeks of the protocol suppressed the increase in body weight of HBRE rats compared to H rats 
(Figure 5A). To identify the effect of black rice extract with difference in body weight of C 
and CBRE, percentage body weight gain was calculated for the increase in body weight from 
week 8 to 16. The percentage body weight gain was unchanged by the black rice extract in 
CBRE rats compared to C rats while it was decreased in HBRE rats compared to H rats (Figure 
5B).  
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Water intake was unchanged between all the groups (Table 4). The food intake was 
higher in C rats compared to H rats (Table 4). Black rice did not change the food intake in 
CBRE and HBRE rats when compared with C and H rats, respectively. Although the energy 
intake values were statistically not different between all the groups, H and HBRE rats had 
higher values compared to C and CBRE rats (Table 4). As a very small quantity (0.4 g/kg) of 
black rice extract was added to the food, the added energy density from the black rice was 
considered to be negligible. Feed efficiency was unchanged by the black rice extract in CBRE 
rats compared to C rats while it was decreased in HBRE rats compared to H rats Table (4). 
3.3 Body composition measurements 
Abdominal circumference in rats followed similar trend to the body weight. After 16 
weeks of HCHF diet feeding, H rats had higher abdominal circumference compared to C rats 
(Figure 5C). Black rice extract did not change the abdominal circumference in CBRE rats 
compared to C rats while it decreased the abdominal circumference in HBRE rats compared to 
H rats (Figure 5C). The total abdominal fat deposition including retroperitoneal, epididymal, 
and omental fat was increased in H rats compared to C rats (Table 4). Black rice did not change 
the abdominal fat depositions in CBRE and HBRE rats when compared with C and H rats, 
respectively. 
The dual X-ray absorptiometry scan provided data for lean mass, fat mass, bone mineral 
content and bone mineral density (Figure 6A-D). The fat mass was higher in H rats compared 
to C rats (Figure 6A). Black rice extract did not change the fat mass in CBRE and HBRE rats 
when compared with C and H rats, respectively (Figure 6A). There were no differences in lean 
mass between all the groups (Figure 6B). Visceral adiposity index was higher in H rats 
compared C rats and it was unaffected by the black rice extract in either of the treated groups 
(Table 4). 
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Bone mineral content was higher in H rats compared to C rats (Figure 6C). Black rice 
extract reduced bone mineral content in HBRE rats compared to H rats while not changing it 
in CBRE rats compared to C rats (Figure 6C). There were no differences in bone mineral 
density between all the groups (Figure 6D). 
3.4 Metabolic variables 
Basal blood glucose concentrations at 16 weeks were elevated in H rats compared to C 
rats (Figure 7A) and consequently the area under the curve was increased (Figure 7B). Black 
rice extract did not improve glucose sensitivity in CBRE rats or HBRE rats. HCHF diet induced 
dyslipidaemia in H rats where plasma concentrations of total cholesterol, triglycerides and 
Nonesterified fatty acids were higher compared to C rats (Table 4). These lipid parameters 
were decreased with black rice extract supplementation. Plasma activities of ALT and AST 
were measured as markers of liver damage. H rats had higher plasma activities of these 
enzymes compared to C rats while black rice supplementation normalised the activities of these 
enzymes in HBRE rats while not changing these activities in CBRE rats. 
3.5 Cardiovascular structure and function 
Systolic blood pressure in H rats was higher compared to HBRE rats. C rats did not 
develop hypertension and remained at ~120 mmHg which is within the normal range. H rats 
progressively increased to develop hypertension (Figure 8A). Black rice extract reduced the 
systolic blood pressure in CBRE and HBRE rats compared to C and H rats, respectively after 
16 weeks on the protocol (Figure 8A). 
At 16 weeks, the diastolic stiffness was increased in H rats compared to C rats (Figure 
8B). There was no difference in diastolic stiffness between C rats and CBRE rats. Black rice 
extract decreased the diastolic stiffness in HBRE rats compared to H rats (Figure 8B). There 
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was no difference in left ventricle + septum wet weight across all the groups (Figure 8C). The 
right ventricle wet weight in H rats was greater than in HBRE rats (Figure 8D).  
The vascular reactivity of the thoracic aorta to acetylcholine, noradrenaline and sodium 
nitroprusside was impaired in H rats compared to C rats shown by the decreased contraction 
and relaxation (Figure 9 A-C). The H rats had decreased force of noradrenaline-induced 
contraction, decreased sodium nitroprusside-induced relaxation and decreased acetylcholine-
induced relaxation compared to C rats (Figure 9 A-C). Both CBRE and HBRE rats showed 
improved forces of contraction and relaxation. In H rats, the collagen deposition in the left 
ventricle was higher than in C rats (Figure 10). Black rice extract decreased the collagen 
deposition in the left ventricle in HBRE rats (Figure 10). 
3.6 Hepatic structure and function 
The H rats exhibited enlargement of the liver compared to C rats (Table 4). There were 
no differences in liver size between CBRE and C rats; HBRE and H rats, respectively. The H 
rat livers had increased infiltration of inflammatory cells and substantial fibrosis (Figure 12). 
The HBRE rats had reduced fibrosis and general inflammation (Figure 12). Liver enzymes 
profile, H rat has increased liver enzyme activity of ALT and AST compared to HBRE rats 
(Table 5). Livers from H rats showed fat depositions as a sign of non-alcoholic fatty liver 
disease. Whereas livers from HBRE rats showed decreased fat. The C rats had normal liver 
structure. HBRE rats showed similar fat deposition in the liver compared to H rats (Figure 12). 
3.7 Gastrointestinal tract structure and function 
 In the ileum organ bath, the C rats had a greater acetylcholine-induced contraction 
compared to H rats (Figure 11A). The HBRE rats showed an improved response. The CBRE 
rats showed an improved response. In the colon organ bath, C rats had a greater acetylcholine-
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induced contraction compared to H rats (Figure 11B). The HBRE rats showed an improved 
response. The CBRE rats showed an improved response. Haematoxylin and eosin staining of 
the ileum (Figure 13) and colon (Figure 14) from the H rats showed an increase in infiltration 
of inflammatory cells compared to C rats. In the CBRE and HBRE rats there was less 
inflammation. 
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Table 4. Effects of black rice extract on physiological variables and body composition 
 
Values are mean ± SEM, n=10-12. Means in a row with superscripts without a common letter differ, P<0.05. 
BRE, black rice extract; C, corn starch diet-fed rats; CBRE, corn starch diet-fed rats supplemented with black rice extract; H, high-carbohydrate high-fat diet-fed rats; HBRE, 
high-carbohydrate high-fat diet-fed rats supplemented with black rice extract. 
 
 
 
Variable C CBRE H HBRE  P-value 
 Diet BRE Diet  BRE 
Initial body weight, g 340 ± 1 341 ± 2 338 ± 1 337 ± 1  0.0283 1.0000 0.4537 
Final body weight, g 379.9 ± 6.9d 408.1 ± 5.8c 555.0 ± 12.1a 490.8 ± 9.8b  <0.0001 0.0410 <0.0001 
Water intake (0-8 weeks), mL/day 28.9 ± 2.9 24.8 ± 3.0 30.4 ± 2.3 30.5 ± 2.8  0.1994 0.4730 0.4513 
Water intake (8-16 weeks), mL/day 29.8 ± 3.0 27.6 ± 3.8 29.9 ± 2.3 34.6 ± 4.1  0.2985 0.7128 0.3121 
Food intake (0-8 weeks), g/day 38.2 ± 3.5a 24.9 ± 1.7b 43.4 ± 2.8a 23.9 ± 1.6b  0.4104 <0.0001 0.2264 
Food intake (8-16 weeks), g/day 36.5 ± 3.6a 26.4 ± 2.5b 41.6 ± 3.0a  23.3 ± 2.3b  0.7443 <0.0001 0.1687 
Energy intake, kJ/day 418.6 ± 40.5 475.5 ± 33.3 548.6 ± 41.8 529.4 ± 39.6  0.0227 0.6307 0.3338 
Food conversion efficiency, g/kJ 0.09 ± 0.01c  0.12 ± 0.01c  0.40 ± 0.02a 0.28 ± 0.01b  <0.0001 0.0014 <0.0001 
Cyanidin 3-glucoside intake, mg/kg 
body weight/day 
N/A 13.7 ± 1.4a N/A 6.9 ± 0.7b  <0.0001 <0.0001 <0.0001 
Bone mineral content, g 11.4 ± 0.1c 11.7 ± 0.2c 16. 2± 0.5a 14.4 ± 0.4b  <0.0001 0.0820 0.337 
Bone mineral density, g/cm2 0.172 ± 0.003 0.170 ± 0.002 0.181 ± 0.002 0.181 ± 0.002  0.9189 0.9894 0.9919 
Total fat mass, g 73.0 ± 4.2b 75.4 ± 7.1b 203.5 ± 15.6a 188.9 ± 11.8a  <0.0001 0.6707 0.5072 
Total lean mass, g 295.5 ± 9.9 309.3 ± 7.1 306.1 ± 10.9 287.1 ± 6.5  0.8365 0.6977 0.0936 
Abdominal circumference at 16 
weeks, cm 
19.2 ± 0.2c 19.5 ± 0.2c 22.0 ± 0.3a 20.8 ± 0.2b  <0.0001 0.0639 0.0023 
Visceral adiposity index, % 4.1 ± 0.1b 4.1 ± 0.4b 7.7 ± 0.6a 8.5 ± 0.6a  <0.0001 0.4010 0.4010 
Body mass index, g/cm2 0.61 ± 0.01d 0.65 ± 0.01c 0.82 ± 0.02a 0.78 ± 0.01b  <0.0001 1.0000 0.0046 
Tissue wet weight, mg/mm tibial 
length 
        
Retroperitoneal  124.5 ± 11.2b 164.7 ± 28.1c 387.6 ± 41.1a 381.7 ± 38.5a  <0.0001 0.0844 0.1217 
Epididymal  79.6 ± 6.7c 83.4 ± 9.2d 176.5 ± 12.9b 215.0 ± 20.1a  <0.0001 0.2437 0.0003 
Omental 116.7 ± 9.39b 90.72 ± 6.70c 225.7 ± 18.4a 252.5 ± 16.1a  <0.0001 0.0089 <0.0001 
Total abdominal fat 320.8 ± 13.3d 338.8 ± 34.0c 789.8 ± 65.9a 849.2 ± 65.8a  <0.0001 0.0377 0.0023 
35 
 
Table 5. Effects of black rice extract on metabolic variables 
 
 
Values are mean ± SEM, n = 10-12. Means in a row with superscripts without a common letter differ, P<0.05 
ALT, alanine transaminase; AST, aspartate transferase; BRE, black rice extract; C, corn starch diet-fed rats; CBRE, corn starch diet-fed rats supplemented with black rice 
extract; H, high-carbohydrate high-fat diet-fed rats; HBRE, high-carbohydrate high-fat diet-fed rats supplemented with black rice extract. 
  
Variable C CBRE H HBRE  P-value 
 Diet BRE Diet  BRE 
Plasma lipid profile         
Total cholesterol, mmol/L 1.71 ± 0.07 1.60 ± 0.09 1.62 ± 0.07 1.62 ± 0.06  0.6360 0.4580 0.4580 
Triglyceride, mmol/L 0.48 ± 0.08c 0.48 ± 0.05c 2.07 ± 0.31a 1.25 ± 0.14b  <0.0001 0.0259 0.0259 
Non-esterified fatty acids, mmol/L 1.13 ± 0.24c 1.21 ± 0.14c 4.29 ± 0.30a 3.41 ± 0.32b  <0.0001 0.1321 0.0727 
Liver enzymes         
Plasma ALT activity, U/L 32.1 ± 4.3b 26.7 ± 2.7b 48.0 ± 5.9a 30.8 ± 3.8b  0.0268 0.0131 0.1816 
Plasma AST activity, U/L 96.5 ±13.6b 77.6 ± 3.5b 162.5 ± 14.0a 85.6 ± 11.5b  0.0027 0.0002 0.0159 
Liver wet weight, mg/mm 220.1 ± 8.8b 250.8 ± 10.5b 325.7 ± 24.9a 341.1 ± 16.3a  <0.0001 0.1664 0.6428 
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Figure 5.  Effects of black rice extract on body weight (A), body weight gain from 8-16 weeks (B) and abdominal circumference (C) in C, 
CBRE, H and HBRE rats. Values are mean ± SEM, n = 10-12. End-point means or overall mean values without a common letter differ, P < 0.05. 
BRE, black rice extract; C, corn starch diet-fed rats; CBRE, corn starch diet-fed rats supplemented with black rice extract; H, high-carbohydrate, 
high-fat diet-fed rats; HBRE, high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract.  
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B
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 P-value 
Figure Diet BRE Diet x BRE 
A <0.0001 0.0410 <0.0001 
B 0.0002 0.1269 0.0011 
C <0.0001 0.0639 0.0023 
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 P-value 
Figure Diet BRE Diet x BRE 
A <0.0001 0.6707 0.5072 
B 0.8365 0.6977 0.0936 
C <0.0001 0.0820 0.0337 
D 0.0012 0.8994 0.8005 
 
Figure 6.  Effects of black rice extract on lean mass (A), fat mass (B), bone mineral content 
(C) and bone mineral density (D) in C, CBRE, H and HBRE rats. Values are mean ± SEM, n 
= 10. Means without a common letter differ, P < 0.05. BRE, black rice extract; C, corn starch 
diet-fed rats; CBRE, corn starch diet-fed rats supplemented with black rice extract; H, high-
carbohydrate, high-fat diet-fed rats; HBRE, high-carbohydrate, high-fat diet-fed rats 
supplemented with black rice extract. 
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Figure 7.  Effects of black rice extract on blood glucose concentration (A) and area under the 
curve (B) in C, CBRE, H and HBRE rats. Data presented as intakes from week 0-8 and 8-16. 
Values are mean ± SEM, n = 10-12. End-point means and overall means without a common 
letter differ, P < 0.05. BRE, black rice extract; C, corn starch diet-fed rats; CBRE, corn starch 
diet-fed rats supplemented with black rice extract; H, high-carbohydrate, high-fat diet-fed rats; 
HBRE, high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract. 
  
A 
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 P-value 
Figure Diet BRE Diet x BRE 
A <0.0001 0.0799 0.7199 
B <0.0001 0.8170 0.4887 
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Figure 8.  Effects of black rice extract on systolic blood pressure (A), diastolic stiffness 
constant (B), left ventricle + septum weight (C) and right ventricle  weight (D) in C, CBRE, H 
and HBRE rats. Values are mean ± SEM, n = 10-12. Means without a common letter differ, P 
< 0.05. BRE, black rice extract; C, corn starch diet-fed rats; CBRE, corn starch diet-fed rats 
supplemented with black rice extract; H, high-carbohydrate, high-fat diet-fed rats; HBRE, 
high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract. 
 
  
A 
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D 
 
 
 
 P-value 
Figure Diet BRE Diet x BRE 
A 0.6697 0.1808 0.0006 
B 0.5998 0.8437 0.3402 
C 0.5583 0.5050 0.3750 
D 0.2578 0.5821 0.4461 
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Figure 9.  Effects of black rice extract on acetylcholine-induced relaxation (A), noradrenaline-
induced contraction (B) and sodium nitroprusside-induced relaxation (C) in thoracic aortic 
preparations from C, CBRE, H and HBRE rats. Values are mean ± SEM, n = 10-12. End-point 
means without a common letter differ, P < 0.05. BRE, black rice extract; C, corn starch diet-
fed rats; CBRE, corn starch diet-fed rats supplemented with black rice extract; H, high-
carbohydrate, high-fat diet-fed rats; HBRE, high-carbohydrate, high-fat diet-fed rats 
supplemented with black rice extract. 
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 P-value 
Figure Diet BRE Diet x 
BRE 
A 0.4931 0.0261 0.1685 
B 0.4201 0.4525 0.2398 
C 0.7054 0.8117 0.4115 
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Figure 10. Effects of black rice extract on collagen (marked as ‘cg’) deposition in hearts using picrosirius red stain at 20x in C, corn starch diet-
fed rats (A); CBRE, corn starch diet-fed rats supplemented with black rice extract (B) H, high-carbohydrate, high-fat diet-fed rats (C); HBRE, 
high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract (D). 
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 P-value 
Figure Diet BRE Diet x BRE 
A 0.1148 0.9739 0.1666 
B 0.3250 0.6063 0.2447 
 
Figure 11.  Effects of black rice extract on acetylcholine-induced relaxation in distal ileum 
preparation (A) and acetylcholine-induced relaxation in distal colon preparation (B) in C, 
CBRE, H and HBRE rats. Values are mean ± SEM, n = 6-8. End-point means without a 
common letter differ, P < 0.05. BRE, black rice extract; C, corn starch diet-fed rats; CBRE, 
corn starch diet-fed rats supplemented with black rice extract; H, high-carbohydrate, high-fat 
diet-fed rats; HBRE, high-carbohydrate, high-fat diet-fed rats supplemented with black rice 
extract. 
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Figure 12. Effects of black rice extract on fat deposition and inflammation in the liver. A–D represent hematoxylin and eosin staining of the liver 
showing fat deposition (marked as ‘vc’) and inflammatory cells (marked as ‘in) (20x) in C, corn starch diet-fed rats; CBRE, corn starch diet-fed 
rats supplemented with black rice extract; H, high-carbohydrate, high-fat diet-fed rats; HBRE, high-carbohydrate, high-fat diet-fed rats 
supplemented with black rice extract. 
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Figure 13. Effects of black rice extract on inflammation in small intestine using haematoxylin and eosin stain (20x) showing inflammatory cells 
(marked as “ic”) in C, corn starch diet-fed rats (A); CBRE, corn starch diet-fed rats supplemented with black rice extract (B) H, high-carbohydrate, 
high-fat diet-fed rats (C); HBRE, high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract (D). 
 
 
Figure 14. Effects of black rice extract on inflammation in large intestine using haematoxylin and eosin stain (20x) showing inflammatory cells 
(marked as “ic”) in C, corn starch diet-fed rats (A); CBRE, corn starch diet-fed rats supplemented with black rice extract (B) H, high-carbohydrate, 
high-fat diet-fed rats (C); HBRE, high-carbohydrate, high-fat diet-fed rats supplemented with black rice extract (D). 
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CHAPTER 4 
DISCUSSION 
This study identified health benefits of cyanidin 3-glucoside from black rice extract in 
a rat model of diet-induced metabolic syndrome. This study has extended the results obtained 
from previous studies at the University of Southern Queensland using the functional foods 
containing anthocyanins. Previous studies with purple carrots and Queen Garnet plum 
containing cyanidin 3-glucoside showed attenuation of diet-induced metabolic syndrome. This 
study used the same dose of cyanidin 3-glucoside as in the Queen Garnet plum study (28). 
Purple carrot study had used a higher dose of cyanidin 3-glucoside to obtain similar results as 
with Queen Garnet plums (28, 57), thus indicating the 8 mg/kg body weight/day as the effective 
dose of cyanidin 3-glucoside against diet-induced metabolic syndrome and obesity. 
4.1 Diet-induced metabolic syndrome 
The combination of feeding a high-carbohydrate, high-fat diet to rats for 16 weeks was 
used to mimic the human metabolic syndrome as in the previous studies (26, 28, 57). The high-
carbohydrate, high-fat diet induced metabolic syndrome in rats including central obesity, 
dyslipidaemia, impaired glucose tolerance and hypertension. These changes were also 
accompanied with the alterations in structure and function of the cardiovascular, hepatic and 
gastrointestinal systems. The changes in the cardiovascular system included hypertension, 
increased diastolic stiffness, inflammation, fibrosis and endothelial dysfunction whereas the 
liver changes included hypertrophy, inflammation and steatosis along with increased plasma 
activity of liver enzymes (ALT and AST). This rat model is validated and has been used to 
identify potential benefits of various functional foods against diet-induced metabolic syndrome 
(27, 28, 57, 85, 86). 
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CS diet was used as control healthy diet for identifying the metabolic syndrome-
associated changes in HCHF diet-fed rats. CS diet was rich in complex polysaccharide and 
hence it was able to provide balanced metabolism for the rats whereas the HCHF diet contained 
fructose and sucrose (26). Excess fructose (and sucrose as it breaks down to glucose and 
fructose) consumption has been linked to the development of metabolic complications (87, 88) 
and it has been shown to be the major contributing factor for the development of obesity (88). 
Unlike fructose, corn starch does not increase systolic blood pressure, abdominal fat deposition 
and concentration of blood glucose and plasma lipids (26). Moreover, the HCHF diet contained 
long-chain saturated and trans fatty acids. There are clear evidence that suggest that these fatty 
acids can initiate metabolic impairments and hence contribute towards the development of 
metabolic syndrome (89). 
4.2 Significance 
Obesity is a major medical problem exacerbating several health conditions such as type 
2 diabetes, hypertension and dyslipidaemia (90). Although the prevalence of obesity has 
increased throughout the world, there are no suitable treatments available for it (4) especially 
the pharmacological approaches being associated with various complications (4, 91). 
Therefore, it has been proposed that functional foods, foods with defined health benefits, may 
be the alternative to be used as a treatment for obesity (4). Foods containing polyphenols, 
especially the anthocyanins, have many beneficial health effects associated with them (92), 
although they have a low bioavailability (93). 
4.3 Black rice 
Rice is an important crop and a staple food for more than half the world’s population 
(94). Black rice (Oryza sativa L.) originated from South-Eastern Asia in the early 1200s (94). 
It has high levels of cyanidin 3-glucoside and hence the colour, along with high levels of iron 
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and vitamin E. The bran hull (outermost layer) contains one of the highest levels of 
anthocyanins found in food (higher by weight than any other coloured grains). Black rice also 
contains small quantities of amylose and amylopectin, the two components of starch. The black 
rice extract used in this study contained 36% cyanidin 3-glucoside with ~2% other 
anthocyanins. 
In this study, black rice extract reduced body weight at the end of the protocol, however, 
it did not change the abdominal fat or total body fat content. In a recently published study, the 
body weight, abdominal fat and total body fat were reduced with a similar dose of cyanidin 3-
glucoside as a pure compound as well as from Queen Garnet plum juice (57). In the purple 
carrot study, body weight and abdominal fat were reduced with the purple carrot juice with 
total body fat data unavailable (28). A recent report analysing the effects of functional foods 
including foods containing anthocyanins supports the reduction in body weight and abdominal 
fat reduction but black rice extract was unable to reduce the abdominal fat (4). Abdominal 
obesity has been linked with many pathophysiological complications including dyslipidaemia, 
cardiovascular disease and insulin resistance (95-97). So, with no change in abdominal fat, it 
was expected that the complications of metabolic syndrome would remain in the treated 
animals. According to a previous study, coffee extract did not reduce body weight and 
abdominal fat but it was still able to produce improvements in other complications of metabolic 
syndrome (98). 
Anthocyanin bioavailability is lower than other polyphenols with only 1% being 
absorbed (99).  In animal models, anthocyanins administered at relatively high dosages (1-2 
mg/kg diet) are protective against oxidative stress (100). Dosage for this study was 8 mg/kg 
diet of total anthocyanins of which approximately 36% was in the form of cyanidin 3-glucoside 
(therefore, 2.8 mg/kg diet of cyanidin 3-glucoside was used). This cyanidin 3-glucoside dose 
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was previously investigated using purple carrot juice (dose of 5% in food for 8 weeks) using 
the 16-week high-carbohydrate, high-fat model (28). The results in this study supported the 
evidence that anthocyanins have beneficial health effects. Dietary phenols are divided into one 
third phenolic acids and two thirds flavonoids (101). The CBRE and HBRE rats had 
significantly reduced systolic blood pressure, abdominal obesity, body weight gain, diastolic 
stiffness along with reductions in inflammatory cells in the liver and heart. There was also 
reduced collagen deposition in the left ventricle of the heart. In a study (n= 920) conducted in 
Germany, investigated the consumption of young people (age 4-14 years) and found that 
anthocyanidin intake among the group was 6 mg/day, with strawberries representing the main 
source (102). Anthocyanins are widely ingested with median values of 180 mg/day, many 
derived from fruits and wines (103). It is evident that anthocyanins are consumed more widely 
than their sugar-free form (anthocyanidins). The HBRE rats showed 10% body weight 
reduction compared to H rats. Additionally, the HBRE line (Figure 6A) was beginning to 
plateau demonstrating body weight was maintained, which is the first stage to weight loss. The 
reduction in the overall body weight of HBRE rats is correlated to the reduction in abdominal 
fat deposition and is possibly due to the up-regulation of adiponectin. Adiponectin is an 
adipokine that has a role in the regulation of glucose concentrations and fatty acid catabolism. 
4.4 Cardiovascular effects 
4.4.1 Diastolic stiffness 
Myocardial fibrosis, the major mechanism in the development of left ventricular 
dysfunction, results from disproportionate collagen deposition accompanied by reduced 
degradation of extracellular matrix leading to an increased tissue stiffness (26). 
The left ventricle diastolic stiffness was higher in H rats compared to C rats (Figure 
7B). Black rice extract decreased the diastolic stiffness in CBRE and HBRE rats. An increased 
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left ventricle stiffness correlates to a reduced heart function, decreasing the efficiency with 
which the oxygenated blood is pumped around the systemic circulation. This reduces the 
perfusion to tissues in the body. Hence, there is reduced oxygen and nutrient are transportation 
to tissues with decreased waste removal occurring. This is detrimental to the overall health and 
wellbeing of the individual. 
4.4.2 Endothelial function 
The cyclic guanosine monophosphate (cGMP) secondary messenger pathway for nitric 
oxide and endothelial function carried out in the cytoplasm. Guanylyl cyclase (converts GTP 
to cGMP). Protein kinase G to have vasodilatory effects. Nitric oxide is a metabolite of sodium 
nitroprusside. Build of cGMP stimulates protein kinase G which adds a phosphate group to the 
molecule. Phosphorylated protein activates the function which is vasodilation. Vasodilatory 
effects lower the pre-load on the heart, which decreases the volume of blood in the heart at the 
end of diastole (104). 
Fatty acid oxidation (β-oxidation) occurs in the mitochondria to generate acetyl-CoA, 
NADH and FADH2. Obesity occurs when triglycerides are stored as fat tissue instead of being 
utilised for energy production. Fatty acid degradation involves three stages. Stage one is β-
oxidation cleaves two carbons at a time. Electrons carriers are NADH and FADH2. Stage two 
is Krebs cycle where acetyl-CoA is consumed. Stage three is the electron transport chain 
(similar to aerobic respiration) to generate energy in the form of adenosine tri-phosphate (105). 
Cholesteryl ester transfer protein facilities the transfer of triglycerides between 
lipoproteins. This protein is involved in transfer of cholesteryl ester from HDL to other 
lipoproteins. Black rice extract can modulate this pathway causing decreased atherosclerotic 
plaque build-up. Vasodilation is the widening of blood vessels. Impaired vasodilation increases 
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the cardiovascular risk. Endothelium-dependent vasodilation is lost with increasing age. 
Cholesteryl ester transfer proteins are a novel target for increasing HDL levels (106). 
4.4.3 Systolic blood pressure 
Cyanidin 3-glucoside reduced the systolic blood pressure possibly through inhibition 
of angiotensin converting enzyme (ACE) (107). ACE is produced in the lung and functions in 
converting angiotensin I to angiotensin II (a potent vasoconstrictor). ACE is important in 
homeostasis and regulation of blood volume and thus blood pressure (108). ACE acts to 
decrease peripheral vascular resistance which leads to a decrease in blood pressure (109). The 
improvement of approximately 20 mmHg is substantial because it demonstrates the positive 
effect black rice extract had on normalising the systolic blood pressure thus decreasing the risk 
of developing cardiovascular diseases. The normal systolic blood pressure for all rats at 0 
weeks was approximately 120 mmHg. The vascular reactivity seen in thoracic aorta rings organ 
bath showed an improvement in endothelial function shown by improved contraction and 
relaxation respective to the drug used. Improved endothelial function is seen by an increased 
production of nitric oxide synthase (NOS), consequently causing vasodilation of the blood 
vessels in vivo. Nitric oxide has three isoforms: neuronal (nNOS), inducible (iNOS) and 
endothelial (eNOS). The eNOS was possibly increased. In rats, the absorption rate of 
anthocyanins is less predictable than other flavonoids such as tea catechin (110). In humans, 
the absorption rate of anthocyanins is less than tea catechins (110). 
Black rice suppresses the nitric oxide and reactive chemical species in a biological 
model (94). In a study conducted in China, also using black rice extract it was found that the 
formation of nitric oxide through suppression of iNOS in macrophages from murine cells was 
significantly reduced (P<0.05) (94). Black rice decreases atherosclerotic plaque formation and 
increases the antioxidant status in rabbits (111). Cyanidin 3-glucopyransoide is metabolised in 
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the liver by catechol-O-methyltransferase into two metabolites, Pn3G and 4’-O-methyl-Cy3G 
(112). A study found that the structure of the glucoside affects its absorption and overall 
bioavailability. The increase in number of hydroxyl groups in the molecule decreases its 
availability (113). 
4.5 Oxidative stress 
Oxidative stress is caused by an imbalance between the production of reactive oxygen 
species (ROS) and their detoxification in biological systems (114). Oxidative stress potentiates 
ageing and chronic degenerative diseases (47). The consumption of dietary antioxidants 
reduces this effect. Obesity is associated with systemic oxidative stress, adipokine imbalance 
and reduced antioxidant defences, leading to dyslipidemia, vascular disease and hepatic 
steatosis (115). Cyanidin 3-glucoside functions as a free radical scavenger, i.e. removing toxic 
ROS from cells (107). The role of anthocyanins in cardiovascular disease protection is strongly 
linked to decreased oxidative stress production (82). Anthocyanins have diverse 
pharmacological actions including their antioxidant activity and protective effects against DNA 
damage, induced hepatic toxicity in rats and peroxidase activity in human’s blood (116). ROS 
generation occurs when the unstable unpaired electrons, generated from metabolism by-
products, cause damage to the cells and tissues (117). When blood flow is interrupted (hypoxia) 
to a tissue, ischemia occurs. The absence of blood and nutrients creates a problem when blood 
flow is returned and the tissue is perfused once again. The ROS species cause inflammation 
and oxidative damage to the tissue, causing a reperfusion injury. Orally administered cyanidin 
3-glucoside attenuates hepatic ischemia reperfusion injury (118). Prolonged oxidative stress 
results in the uptake of glucose in both muscle and adipose tissue and decreases insulin 
secretion from pancreatic β-cells, thereby accelerating the pathological development of type 2 
diabetes (80). 
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A study showed that anti-oxidative effects exerted by black rice extract are mediated 
through decreases in free-radical generation as well as increases in superoxide dismutase and 
catalase activities both in vitro and in vivo (119). Anthocyanins have direct protective effects 
on the heart. Hearts from male Wistar rats fed on a diet based on anthocyanins containing maize 
kernels for eight weeks were more resistant to regional ischemia and reperfusion insult induced 
in an isolated heart preparation (62). This diet also reduced the infarct size in a coronary 
occlusion and reperfusion model (62). 
4.6 Diabetes and non-alcoholic fatty liver disease 
Diabetes is a glucose regulation disorder and of growing health concern with 
approximately 2.8% of the world population diagnosed with diabetes in 2000 (38). There are 
two types of diabetes; type 1 affects 10% of the diabetics and is insulin independent with 
juvenile onset (strong genetic role); type 2 affects 90% of diabetics and is insulin dependent. 
The onset of type 2 diabetes is lifestyle, mainlydiet problems. Diabetes is set to increase due to 
the increasing proportion of the population who are 65 years and older. This increasing age 
will have greater impact in contributing to increased worldwide prevalence (38). Diabetic 
complications include liver problems, ranging from non-progressive steatosis to non-alcoholic 
fatty liver disease (NAFLD) (120). NAFLD is characterised by excessive lipid accumulation 
in the liver, manifesting the signs of metabolic syndrome and insulin resistance (99). NAFLD 
is the most common hepatic manifestation among metabolic disease, diabetes and obesity 
(121). In studies of type 2 diabetes and metabolic syndrome, the related risk factors including 
the consumption of energy-rich food has been linked to increased risk of developing these 
disease states (122). Cyanidin 3-glucoside from black berry extract inhibits nitric oxide 
biosynthesis (123). Diabetes is associated with oxidative stress caused from hyperglycaemia 
and hyperlipidaemia (122). The increased carbonyl stress (includes both oxidative and non-
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oxidative stress) is possibly due to substrate overload and or deficiencies in detoxification 
pathways (124). The oral glucose tolerance test showed H rats to have an increased fasting 
blood glucose level. This correlates to a lack of insulin sensitivity and possibly in extremes 
cases such as diabetes and insulin resistance. There was a decreased sensitivity to glucose in H 
rats compared to C rats. This means higher basal blood glucose levels with an increased area 
under the curve for the H rats. Black rice extract did not improve blood glucose sensitivity. 
Blood glucose concentrations are controlled by the pancreas. In healthy individuals, the 
pancreatic β-cells located in the islets of Langerhans secrete insulin. After food consumption, 
insulin is released from the pancreatic β-cells to assist in glucose-uptake into the cell. Incretins 
are a useful group of hormones that increase insulin production, used as treatment for type 2 
diabetics (125). The two most important incretins are glucagon like pepide-1 and glucose-
dependent insulinotropic polypeptide (125). Obesity is a complex energy imbalance disorder 
with complications leading to the development of metabolic syndrome. In healthy individuals 
the endocrine system regulates several hormones, e.g. ghrelin, leptin and adiponectin in 
conjunction to maintain homeostatic, however in disease states such as metabolic syndrome 
the regulation is disrupted and obesity occurs. 
4.7 Inflammation 
 Inflammation occurs in every organ in the body and is the typical response to cell 
damage and vascularised tissue injury (126). Inflammation has a protective function to foreign 
antigens; however over inflammation is a problem. Enzymes and lipid mediators are released 
after cell damage occurs. Leukotrienes are a group of G-coupled receptors originally from 
isolated leukocytes. They are formed by oxidation of arachidonic acid and eicosanoid 
inflammatory mediators. Their function is to sustain inflammatory reactions. 
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4.8 Black rice extract health claims 
The black rice extract (ProC3G) provided by ChromaDex claims the following health 
benefits: improved cholesterol levels and vasodilation (decreases CVD), glucose metabolism 
(promotion of superoxide dismutase (SOD) activity),  weight loss – anthocyanins influence the 
gene expression for fat metabolism, signalling body to burn fat and not store it, Anti-aging 
(contains antioxidants to defend against free radicals generated by oxidative stress). Black rice 
is claimed to  include benefits for multiple organs specifically the kidney, liver and stomach. 
This study provided evidence to support that black rice extract decreases systolic blood 
pressure, reduces inflammation in the liver and reduces the overall body weight. 
4.9 Anthocyanin mechanism of action 
Mechanistic studies support the beneficial health effects of anthocyanins on the 
established biomarkers of cardiovascular disease which are nitric oxide, inflammation and 
endothelial dysfunction (64). The role of anthocyanins in cardiovascular disease prevention is 
strongly linked to protection against oxidative stress (64). Several mechanisms of action have 
been proposed to explain the anti-inflammatory actions of anthocyanins. Specifically these 
compounds may provide protection from DNA cleavage, enzyme inhibition, increased anti-
inflammatory cytokine production, decreased lipid peroxidation, decreased capillary 
permeability, fragility and membrane strengthening (64). Commercial grape juice (10 mL/kg) 
has been shown to significantly inhibit platelet activity and experimental coronary thrombosis 
in vivo (127). Corn-derived anthocyanins made the myocardium less susceptible to ischemia 
reperfusion injury ex vivo and in vivo compared with the anthocyanin-free control (64). 
NF-κB is a transcription factor activated by oxidative stress and pro-inflammatory 
stimuli and controls the expression of numerous genes involved in inflammation. Anthocyanins 
exert their effects through  blocking NF-κB. Dampening NF-κB expression will thereby limit 
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the inflammatory response (84). The extent to which anthocyanins exert their effects can be 
measured through decreased plasma concentrations of pro-inflammatory chemokines, 
cytokines and inflammatory mediators (84). 
4.10 Mice studies 
Mice studies can also be used to study different aspects where anthocyanins have 
action. The benefit of mice studies include genetic modification, to ‘knock out’ or ‘knock in’ 
genes, e.g. knockout mice. The alteration of existing genes with modified genes focuses the 
study area. Heart disease uses Apoe knockout mouse and C57BL/6J. Type 2 diabetes The 
Jackson Laboratory: Cpefat, Lepob, Leprdb and tub (128). In type 2 diabetic mice cyanidin 3-
glucoside ameliorates hyperglycaemia and insulin insensitivity due to the reduction of retinol 
binding protein 4 expression (129). Orally administered cyanidin 3-glucoside is metabolised to 
protocatechuic acid via cyanidin by intestinal microbiota (130). Anti-scratching effects of black 
coloured rice for diseases such as dermatitis, rhinitis, and psoriasis (130). Cyanidin 3-glucoside 
metabolites also exhibited inhibition the expression of allergic cytokines such as IL-4, TNF-α 
and activation of their transcription factor, NF-κB in RBL-2H3 cells stimulated with IgE-
antigen. Anthocyanin fraction from purple sweet potato decreases hepatic triglyceride 
accumulation through AMPK-mediated modulation of fatty acid metabolism, potentially 
ameliorating hyperkaliemia (131). Black rice extract attenuates hepatic steatosis in mice fed a 
high fat diet via fatty acid oxidation (132). 
4.11 Limitations 
Due to the time constraints and unforeseen delays, plasma analyses, gastrointestinal 
tract  microbiota characterisation and Western Blot analyses were not completed. However, 
plasma was taken, faecal samples were collected for gut microbiota studies and tissue samples 
(liver, heart, pancreas, small and large and intestines) were collected for Western Blot studies 
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to be completed in the future. Pancreas tissue samples for histopathological analysis was 
collected but not used. The limitation in using a rodent model to study disease is the difficulty 
in translating positive results into higher order organisms such as humans. This requires human 
testing to provide further evidence-based validation before wide scale health claims can be 
made. 
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CHAPTER 5 
5.1 SUMMARY AND CONCLUSION 
 The major finding from this study was that black rice extract attenuated or normalised 
signs of metabolic syndrome in high-carbohydrate, high-fat fed rats. Rats supplemented with 
black rice extract rats while still fed a high-carbohydrate, high-fat diet showed reduced 
abdominal obesity and overall body weight. Cardiovascular structure and function was 
improved with marked reductions in systolic blood pressure, inflammatory cell infiltration and 
fibrosis. Liver structure and function was improved as demonstrated by reduced inflammation. 
The gastrointestinal tract was improved with a decreased amount of general inflammation in 
the small and large intestines. Hence, black rice extract can provide cardiovascular, hepatic and 
gastrointestinal protection along with cholesterol modulation. A small dietary change in 
swapping brown rice to black rice or supplementing black rice into the human diet may offer 
health benefits. This study further extended the body of evidence that anthocyanins have 
functional food qualities. In particular, this study supports health claims for foods containing 
cyanidin 3-glucoside to improve the signs associated with metabolic syndrome. Further 
investigations are required to determine if these health benefits can translate to overweight or 
obese humans. 
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5.2 FUTURE DIRECTIONS 
A 16-week high-carbohydrate, high-fat diet was used to model most of the systemic 
effects seen in the metabolic syndrome. Metabolic syndrome affects multiple organ systems 
including cardiovascular, hepatic and endocrine. The human body is a highly complex 
organism which cannot be ethically studied in vivo without validated evidence conducted on 
an animal model. The animal model must effectively mimic most of metabolic syndrome 
effects on the body. The translation of the results from an animal model (pre-clinical) to the 
gold standard of human clinical trials is important. Eventually, provided positive effects are 
seen, this black rice extract treatment can be tested in the human system. Insulin activity 
measurements can be used to determine if the insulin sensitivity to glucose.. Gene expression 
for weight loss  would be useful in order to determine the  expression of  genes, proteins and 
hormones including such adiponectin and leptin in the treatment rats. 
5.2.1 Gut microbiota (meta-genomic) analysis method 
Faecal samples from rats will be collected immediately following euthanasia and stored 
at -80°C for analysis of the gut microbiota. Frozen samples will be delivered to the Australian 
Genome Research Facility (AGRF), Brisbane, Queensland, Australia. DNA from rat stool 
samples will be isolated by staff at AGRF and then sequenced on 1 x lane of MiSeq with 300bp 
paired-end reads using Illumina SBS (provides high speed, multiplex 16S amplicon sequencing 
on the MiSeq® system) to identify the various microbial organisms in the provided samples. 
Bioinformatics reports for Operational Taxonomic Unit (OTU) chart up to phylum/family level 
and reporting of taxonomic distribution will be provided by AGRF using their in-house 
analytical techniques. 
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5.2.2 Gene sequencing method 
 16S rRNA useful for identification of bacteria and species profiling (133). An 
investigation into the different regions of the gut (proximal, mid, distal) may determine the 
effect diet has on the variance of bacterial species. The gut microbiota impacts the metabolism 
and overall health of the host (134). 
5.2.3 Polymerase chain reaction method 
Polymerase chain reaction (PCR) is used to amplify DNA to several orders of 
magnitude which is good for DNA sequencing. PCR involves a three step process. Step one – 
denaturation of the DNA strands, separate into separate strands. Taq polymerase to synthesis 
more strands. Step two – anneal the strands. Step three – amplification of strands. 
5.2.4 Western Blot method 
 Separate and identify specific amino acid sequence from protein mixture. Cell lysis to 
extract proteins, gel preparation, transfer, gel electrophoresis, electro transfer, blocking and 
antibody incubation (135). 
5.2.5 Biochemical measurement methods 
For oxidative stress the plasma concentrations of malondialdehyde may be measured. 
As obesity is a chronic low-grade inflammatory condition it would be useful to measure the 
CRP levels. The following cytokines would be useful to measure the concentrations of leptin, 
ghrelin and adiponectin. 
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5.2.6mRNA methods 
 mRNA studies indicate obesity has a strong genetic predisposition (136). 
Investigating mRNA expression and distribution in the adipose tissue of rats may lead to a 
better understanding of the physiology and hence clinical implications of a variety of genes. 
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